Quest Diagnostics Inc vs Open Text Corporation — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Open Text Corporation trades at $23.7 (market cap $5.61B). The key difference: Quest Diagnostics Inc is far larger — about 4.5× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.82%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Open Text Corporation for 23 Days on average.
| DGX | OTEX | |
|---|---|---|
Market Cap | $25.48B | $5.61B |
Volume | 941,866 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $247.45 | $39.69 |
52-Week Low | $173.49 | $20.01 |
Typical Hold Time | 56 Days | 23 Days |
Enterprise Value | $31.23B | $10.63B |
Dividend Yield | 1.49% | 4.82% |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
OpenText (OTEX) trades at $23.24, up 0.43% with a bearish technical signal despite strong fundamentals. The company shows robust profitability with 73.74% gross margins and consistent earnings beats, while actively managing debt through recent $1 billion notes offering. Valuation appears attractive with P/E of 9.01 and P/S of 1.1, trading below analyst consensus target of $28.30.
The stock presents value opportunity with discounted multiples and improving cloud momentum, though technical weakness and debt refinancing activities warrant caution. Upside potential exists if earnings growth continues, while execution risks and market sentiment remain key watchpoints for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →